Jiangsu Bioperfectus Technologies Co., Ltd. (SHSE: 688399)
Health Care · Health Care Equipment & Supplies · CN
CN¥28.64
-4.37% today · -34.4% 1Y
Jiangsu Bioperfectus Technologies Co., Ltd. (SHSE: 688399) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $528.84M and employs 581 people.
Over the last twelve months the share price has lost 34.4%, trading between 23.24 and 63.51.
Tweenvest scores Jiangsu Bioperfectus Technologies Co., Ltd. across four factors: quality 63/100, value 65/100, growth 0/100. Its strongest factor is value.
688399 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $528.84M
- Revenue (TTM)
- $47.27M
- P/E
- —
- EPS
- -0.26
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- CN¥63.51
- 52-week low
- CN¥23.24
- Avg volume (3M)
- —
- Shares outstanding
- 124.13M
- Employees
- 581
- Next earnings
- —
About Jiangsu Bioperfectus Technologies Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) solutions across China. The company's core offerings include a range of diagnostic reagents, complementary detection equipment, and comprehensive in vitro testing services. Established in 2010, its operations are based in Taizhou, China.
- ISIN
- CNE1000055B2
- Founded
- 2010
- Listed since
- Dec 5, 2019
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.00 | -0.11% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $372.64 | +0.22% |
| Stryker CorporationNYSE: SYK | $126.81B | $331.82 | +0.37% |
| Medtronic plcNYSE: MDT | $116.66B | $91.10 | -0.04% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.15 | +0.63% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $48.40 | -2.93% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.